Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clotting. This medication is manufactured by Advanz Pharma Limited in the EU.

Aggrastat is primarily used to prevent blood clots in patients undergoing procedures like angioplasty or those with acute coronary syndrome. It works by inhibiting platelet aggregation, which helps maintain blood flow and reduces the risk of clotting. Patients may be prescribed Aggrastat when other treatments are not suitable or effective.

Common effects of Aggrastat may include bleeding, bruising, and low blood pressure. Some patients may experience nausea or dizziness. These effects are generally mild and temporary, but any severe or persistent symptoms should be discussed with a healthcare provider.

Aggrastat should be handled with care, as it is intended for intravenous use only. It is important to follow the administration guidelines provided by a healthcare professional. Patients with a history of bleeding disorders or recent surgery should inform their healthcare provider before using Aggrastat.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Aggrastat.